Cortisol and 17-Hydroxyprogesterone Kinetics in Saliva after Oral Administration of Hydrocortisone in Children and Young Adolescents with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency (original ) (raw )Oral Hydrocortisone Administration in Children with Classic 21-Hydroxylase Deficiency Leads to More Synchronous Joint GH and Cortisol Secretion
Atholl Johnston
The Journal of Clinical Endocrinology & Metabolism, 2002
View PDFchevron_right
Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia
Didier Dewailly
Fertility and Sterility, 2000
View PDFchevron_right
Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Atholl Johnston
Journal of Endocrinology, 2001
View PDFchevron_right
Pharmacokinetic Evidence for Suboptimal Treatment of Adrenal Insufficiency with Currently Available Hydrocortisone Tablets
Thierry Brue
Clinical Pharmacokinetics, 2010
View PDFchevron_right
Effect of Cortisol Treatment on Hormonal Relationships in Congenital Adrenal Hyperplasia
Robert Kelch
Clinical Endocrinology, 1977
View PDFchevron_right
Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia
Claudio Kater
Archives of Disease in Childhood, 1997
View PDFchevron_right
Salivary 17-Hydroxyprogesterone (17-OHP) and Androstenedionein Monitoring Efficacy of Treatment Among Indonesian Congenital Adrenal Hyperplasia Patients
Stenvert Drop
Journal of the ASEAN Federation of Endocrine Societies, 2012
View PDFchevron_right
A phase 2 study of chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia
Lynnette Nieman
The Journal of clinical endocrinology and metabolism, 2015
View PDFchevron_right
Adrenomedullary Function in Patients with Nonclassic Congenital Adrenal Hyperplasia
somya verma
Hormone and Metabolic Research, 2010
View PDFchevron_right
Measurement of Salivary Adrenal-Specific Androgens as Biomarkers of Therapy Control in 21-Hydroxylase Deficiency
Irina Bacila
The Journal of Clinical Endocrinology & Metabolism, 2019
View PDFchevron_right
Comparison of cortisol exposures and pharmacodynamic adrenal steroid responses to hydrocortisone suspension vs. commercial tablets
Kyriakie Sarafoglou
The Journal of Clinical Pharmacology, 2014
View PDFchevron_right
Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-Deoxycortisol in Classic Congenital Adrenal Hyperplasia: Clinical and Hormonal Correlations and Identification of Patients with 11β-Hydroxylase Deficiency among a Large Group with Alleged 21-Hydroxylase Deficiency
Claudio Kater
The Journal of Clinical Endocrinology & Metabolism, 2006
View PDFchevron_right
Variation in serum adrenal hormones in female 21-hydroxylase deficient patients
Mikkel Andreassen
Endocrine Connections
View PDFchevron_right
ADRENAL INSUFFICIENCY: CURRENT THERAPEUTIC REPLACEMENT STRATEGIES. IS THERE ANY EVIDENCE OF IMPROVED CLINICAL OUTCOMES WITH THE USE OF ONCE DAILY LONG ACTING HYDROCORTISONE THERAPY
Mustafa Alabousi
View PDFchevron_right
Assessment of Corticoadrenal Reserve Through Salivary Steroids
Liliana Cruz Contreras
The Endocrinologist, 2002
View PDFchevron_right
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
L. Ghizzoni , Phyllis Speiser
Clinical Endocrinology, 1998
View PDFchevron_right
Impact of food, alcohol and pH on modified-release hydrocortisone developed to treat congenital adrenal hyperplasia
Daniel Margetson
European journal of endocrinology, 2017
View PDFchevron_right
Serum Cortisol and 17-Hydroxyprogesterone Interrelation in Classic 21-Hydroxylase Deficiency: Is Current Replacement Therapy Satisfactory?
Atholl Johnston
The Journal of Clinical Endocrinology & Metabolism, 2001
View PDFchevron_right
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of the patient with non-classic CAH due to 21-hydroxylase deficiency
Henrik Falhammar
European journal of endocrinology, 2019
View PDFchevron_right
ADRENARCHE AND GROWTH DURING LHRH AGONIST (LHRHa) ADMINISTRATION
William Crowley
Pediatric Research, 1984
View PDFchevron_right
Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Young-Ah Lee
Journal of Korean medical science, 2011
View PDFchevron_right
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
Phyllis W Speiser
The Journal of Clinical Endocrinology Metabolism, 2013
View PDFchevron_right
The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11beta-hydroxysteroid dehydrogenase activity
John Monson
Clinical Endocrinology, 1998
View PDFchevron_right
BRIEF REPORT Measurement of 18Hydroxycorticosterone during Adrenal Vein Sampling for Primary Aldosteronism
Richard Auchus
2010
View PDFchevron_right
21Hydroxylase–deficient nonclassic adrenal hyperplasia is a progressive disorder: A multicenter study
Carlos Morán
American Journal of Obstetrics and Gynecology, 2000
View PDFchevron_right
Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers
Warrick Inder
BMC endocrine disorders, 2014
View PDFchevron_right